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Abstract 
During the development of parenteral dosage forms, different physicochemical studies are 
required to ensure stable, effective and safe formulations. The osmolality of this kind of 
dosage form should bear a close similarity to the body fluids to prevent local irritation, pain or 
even more significant side effects like endothelial damage. The osmotic studies performed in 5 
Polyethylene glycol 400 (PEG 400), Polyethylene glycol 4000 (PEG 4000), Poloxamer 407 
(P407), Sodium Hyaluronate (SH), Chondroitin Sulphate Sodium (CS), Cremophor RH 40 
(CRE40) and Polyvinyl alcohol (PVA) aqueous solutions, showed that the theoretical 
determination of the osmolality based on their molecular weight as the only determinant 
factor did not agree with the values obtained by the measurement of colligative properties 10 
such as the freezing point depression. The data obtained from this study and its analysis, 
provided predictive equations that can be used as tools in the primary development to estimate 
formulation´s osmolality at different concentrations; and its evolution over a period at the 
hypothetical worst-case scenario of storage temperature.  
Key words 15 
Osmolality, fitting model equations, parenteral pharmaceutical development, Polyethylene 
glycol 400, Polyethylene glycol, 4000 Poloxamer 407, Sodium Hyaluronate, Chondroitin 
Sulphate Sodium, Cremophor Polyvinyl alcohol.  
1. Introduction 
In parenteral preparations, attention should be given to osmolality to prevent local irritation, 20 
pain or endothelial damage. Polymers and surfactants are widely used in this kind of 
preparations (Mathew et al., 2017; Nguyen et al., 2015; Sivashanmugam et al., 2015; Thambi 
et al., 2017) to obtain desired pharmacokinetic characteristics such as prolonged release 
profiles; or to improve drugs solubility and bioavailability, considering the low aqueous 
solubility of most active pharmaceutical ingredients.  25 
Osmolality (Osm) is a measure of the osmotic pressure exerted by a real solution across a 
semipermeable membrane. Like osmotic pressure, other colligative properties of a solution, 
such as vapour pressure lowering, boiling point elevation, and freezing point depression, are 
also directly related to the osmolality of the solution (The United States Pharmacopeial 
Convention, 2017). When the osmotic pressure of a solution is measured by passing it through 30 
a cell membrane and then compared to the blood plasma, we are referring to tonicity 
(Remington, 2013; Wang, 2015). The freezing point depression in comparison to pure water is 
a direct measure of the osmotic concentration, this method is commonly used in 
pharmaceutical development as a fast, easy and accepted method to determine the osmolality 
of ophthalmic and parenteral formulations.  35 
Generally, parenteral, ophthalmic, otic and nasal preparations are preferably isotonic (290 
mOsm/kg) or moderately hypertonic (500 mOsm/kg) (Nony et al., 2001). Hyperosmolality 
leads to a loss of water from the cells which causes cell shrinkage and an increase in cellular 
viscosity (Reinhart et al., 2015). 
Among the wide range of polymers used in the preparation of different drugs, Polyethylene 40 
glycols (PEGs) with a general of formula of HOCH2(CH2OCH2)mCH2OH, are water soluble 
inert polymers essentially non-irritant to the skin. They are classified according to their 
structural formula and molecular weight. Within the typical polyethylene glycols with 
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pharmaceutical significance, the polyethylene glycol 400 (PEG 400) is used in parenteral 
preparations as a solubilising agent and polyethylene glycol 4000 (PEG 4000) is used in 45 
bowel preparation before colonoscopy, radiological procedures, or surgery (Martindale, 
2016a; Paul J Sheskey, 2016a). Hydrogenated Castor Oil derivatives, best known as 
Cremophor, are a series of materials obtained by reacting varying amounts of ethylene oxide 
with either castor oil or hydrogenated castor oil. Cremophor RH 40 (Cre40) is a non-ionic 
solubilizer and emulsifying agent made by reacting one mole of hydrogenated castor oil with 50 
40 moles of ethylene oxide, with a molecular weight of 2500 g/mol (BASF SE Care 
Chemicals Division Pharma Ingredients & Services, 2008; Information, 2010). It is used as a 
solvent in vehicles for oral and topical solutions (Paul J Sheskey, 2016b). Another well-
known non-ionic triblock copolymer is the Poloxamer 407 (P407), with a molecular weight of 
12,500 g/mol and formed by two hydrophilic blocks and one hydrophobic block covalently 55 
bonded, is primarily used as surfactant in pharmaceutical formulations as emulsifying or 
solubilizing agent (Paul J Sheskey, 2015a). It is of great interest, that its micellar 
rearrangement in solution produces changes in viscosity when changing its temperature 
(Viegas and Henry, 1998), making them ideal to confer thermoreversible properties to 
formulations and develop novel controlled release formulations (Arbelaez-Camargo et al., 60 
2016). Hyaluronic acid (HA), a high-molecular-weight polymer of 10 000 000–100 000 000 
Da, is formed by d-glucuronic acid and N-acetyl-d-glucosamine disaccharide units (“Sodium 
Hyaluronate: Pharmaceutical Excipients,” n.d.). This  used in ophthalmic and parenteral 
formulations because of its bioadhesive, therapeutic and biodegradation properties 
(Martindale, 2016b). Among the bio-polymers with bioadhesive properties, the Chrondroitin 65 
sulphate (CS) is a glycosaminoglycans and disaccharide polymer composed of equimolar 
amounts of d-glucuronic acid, d-acetylgalactosamine and sulphates in 10–30 disaccharide 
units (Mason, 2016). With a molecular weight of 463.36854 g/mol and an important 
therapeutic effect in joint cartilage and connective tissue, it is used in different formulations 
not just because of its therapeutic effect, but also, as a bioadhesive in ophthalmic and 70 
parenteral formulations. Polyvinyl alcohol is a non-ionic surfactant obtained by 
polymerisation of vinyl acetate followed by partial or almost complete hydrolysis of polyvinyl 
acetate. Different grades are available and they differ in their degree of polymerisation and 
their degree of hydrolysis, which determine the physical properties of the different grades. 
The mean relative molecular mass lies between 20000 and 150000 (Martindale, 2016c). It is 75 
commonly used to increase the viscosity of ophthalmic preparations thus prolonging contact 
of active ingredient with the eye, in sustained-release formulations for oral administration and 
transdermal patches (Handbook of Pharmaceutical Excipients and Edited by Paul J Sheskey, 
n.d.). 
With the aim of predicting the osmolality of ophthalmic and parenteral formulations that 80 
contain the polymers cited above, we studied the osmolality of the different polymers at 
different concentrations and, over a period, we studied the hypothetical worst-case 
temperature scenario (40 ºC) of storage.  
2. Material and methods 
2.1. Materials 85 
Polyglykol 400 (Polyethylene glycol 400 - PubChem CID: 174) manufactured by Clariant 
(Sulzbach) Germany, batch DEG4005530. Polyethylene glycol 4000 (PEG 4000 - PubChem 
CID: 174) manufactured by Panreac AppliChem (Darmstadt) in Germany, batch A 545663 
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and batch B 708221. Kolliphor® P 407 (Poloxamer 407 - PubChem CID: 24751) 
manufactured by Sigma-Aldrich (St. Louis) in USA, batch A: BCBN0739V, batch B: 90 
BCBQ1330V, percentage polyoxyethylene of 71.5-74.9%. Sodium Hyaluronate (PumChem 
CID: 53447380) distributed by Fagron Iberica S.A.U in Spain, batch L15070231 – OF- 
06185. Chondroitin Sulphate Sodium (PubChem CID: 24766) donated by SDM (Barcelona) 
Spain. Cremophor RH 40 distributed by Fagron Iberica S.A.U in Spain, batch L15080090 – 
OF – 206712. Polyvinyl alcohol (Polyvinyl alcohol - PubChem CID: 11199) manufactured by 95 
Panreac AppliChem (Castellar del Vallès, Barcelona) Spain, batch SP013900. 
 
2.2. Methods 
Aqueous solutions ranging from 0.2% to 20% (weight/weight) depending on the polymer, 
were prepared by mass on a Sartorius ENTRIS224-1S analytical balance (Sartorius AG, 100 
Goettingen, Germany). All the mixtures were put under agitation with a magnetic stirrer until 
complete dissolution. All solutions were prepared using reverse osmosis purified water. 
The osmolality of all solutions was measured just after their preparation (time zero) and after 
15 and 30 days of storage with an Advanced Model 3320 Micro-Osmometer (Advanced 
Instruments, Inc., Norwood, MA).  105 
The device directly reports osmolality from the determination of the concentration of 
solutions by means of freezing-point measurements.  
A high-precision thermister senses the sample temperature, controls the degree of 
supercooling and freezes induction, measuring the freezing point of the sample. 
The sample is supercooled several degrees below its freezing point where it is in an unstable 110 
state, then, by mechanical agitation it's partially crystalized forming an ice water mixture. 
Immediately a liquid/solid equilibrium is maintained when the liberated heat of fusion causes 
a rise in the temperature of the sample toward the plateau temperature. The osmometer 
measures this plateau temperature and calculates the concentration in mOsm/Kg of water 
(Advanced Instruments. INC, 2015).  115 
Storage conditions were control by using a Memmert climatic chamber (Memmert GmbH + 
Co. KG, Schwabach, German), with a control temperature of 40 ± 3 ° C. 
For the statistical analysis, STATGRAPHICS Plus for Windows 5.1. Professional Edition 
1994–2000 from Statpoint Technologies, Inc., 560 Broadview Ave, Suite 201, Warrenton, VA 
20186 was used. Multifactor analysis of variance, linearization (when needed) and multiple 120 
linear regression were performed for all samples to determine the best predictive equation.  
3. Results and discussion  
The need for experimental determination of osmolality has been established and usually 
determined, by measuring the freezing point depression (Remington, Joseph P. (Joseph Price) 
and Beringer, Paul, 2006). Theoretically, osmolality can be calculated from the value of any 125 
colligative property of the solution (The United States Pharmacopeial Convention, 2017), but 
there are not always known and their determination is not regularly affordable in the 
pharmaceutical development field.  
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The dissolution of a solute in a pure solvent induces changes in a direct proportion to the 
solute concentration in the solution´s colligative property (Advanced Instruments. INC, 2015) 130 
• the freezing point is depressed, 
• boiling point is raised, 
• osmotic pressure is increased, and 
• vapor pressure is lowered. 
Determining the concentration of a nonvolatile solute in an aqueous solution can be easy and 135 
precise by measuring its freezing point depression.  
The change in the freezing point of a pure solvent when a solute is dissolved is directly 
proportional to the molar concentration of the solute and can be determined using the 
following equation: 
T = Kf·m 140 
Equation 1.1. Freezing point depression 
Where Δt is the temperature change from the pure solvent's freezing point to the freezing 
point of the solution, Kf is the freeing point depression constant (for water is 1.86 kg°C /mol) 
and·m is the molal concentration of the nonvolatile solute (Chang, 2007). 
Freezing point measurement cannot tell us what the nature of the particles is (size, shape or 145 
conformation); as it only depends on the number of particles in solution. 
For practical purposes, osmolarity (a theoretical quantity) expressed in osmoles per L of a 
solution is widely used (The United States Pharmacopeial Convention, 2017) and calculated 
from the w / v concentration using the Equation 1.2. (Remington, Joseph P. (Joseph Price) and 
Beringer, Paul, 2006).  150 
            
    
 





                
 
   
 
                     
        
   
  
Equation 1.2. Theoretical osmolality 
The number of osmol/mol is equal to 1 for nonelectrolytes and is equal to the number of ions 
per molecule for strong electrolytes. This calculation assumed an ideal solution and omits 
factors such as solvation and interionic forces.  
To compute osmolality from values of theoretical osmolarity (obtained from equation 1.2), a 155 
density of 0.997 g/ml was used (Thiesen et al., 1900). 
When the osmolality of aqueous solutions of different polymers was determined theoretically, 
the values obtained were different from those obtained by the measurement of the freezing 
point depression. In pre-formulation, this can lead to the selection of an unsuitable polymer or 
its concentration and cause errors in the formulation processes lost in time and resources. 160 
These differences were expected as the osmolalities of single-solute solutions are represented 
in the Osmotic Virial Equation (OVE) as polynomials in concentration, where each solute has 
coefficients for terms of second or higher order in concentration (Elliott et al., 2007; Prickett 
et al., 2011), also, interactions between solutes must be taken into account.  
Osmolality of polymers, depend more on the degree of polymerization and the interaction 165 
between the chains, than the number of active particles in solution (molecules or ions) 
(Cloizeaux, 1975; Zavitsas, 2001). 
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3.1. Polyethylene glycol 400 (PEG400) 
PEG 400 is widely used in different pharmaceutical formulations, in parenteral, topical, 
ophthalmic, oral, and rectal preparations (Martindale, 2016a). As far as ophthalmic and 170 
parenteral preparations are concerned, the addition of PEG 400 caused an increase in/mol the 
osmolality, due to its action as a hyperosmolar agent.  
A multifactor analysis of variance for the osmolality of different aqueous PEG 400 solutions 
was performed to determine if the concentration, batch and/or the time have a statistically 
significant effect on the osmolality.  175 
Due to its intrinsic properties and as seen in graphic 1, the theoretical osmolality is exhibits 
quite a difference from the experimental osmolality, especially at high concentrations. This 
effect, observed by other authors (Money, 1989), can be explained by a possible change in the 
PEG`s molecule configuration in response to the change in the concentration; going from 
extended to folded configuration when increasing the concentration. This folded configuration 180 
exposed oxygens that bind with the hydrogens of the water, depressing the thermodynamic 
activity of water and increasing the osmolality.  
In a multifactor analysis of the variance for the PEG’s 400 osmolality, the p-value for 
concentration, time and the interaction between these two factors (AB) were less than 0.05, 
indicating that there is a statistically significant effect on the PEG’s 400 osmolality at the 95 185 
% confidence level for all three factors.  
Graphic 1 shows a strong relation between the osmolality and the PEG 400 concentration and 
time of storage at 40 ºC. 
(Graphic 1) 
To linearized the data obtained, a square root for PEG’s 400 osmolality was applied due to the 190 
quadratic relation showed in the results obtained from the variance analysis with polynomic 
contrast (F-value 152, p-value < 0.01) and explained in Graphic 2.A.  
(Graphic 2) 
To simplify the model, a multiple linear regression using the backward selection method was 
applied to remove from the equation the factor(s) with the highest p-value and no 195 
significance: as a result, the time of storage was removed. As seen in Graphic 2, the simplified 
equation fitted the model and explains 96.9 % of the variability in the square root of the 
osmolality. 
             








Equation 2. Predicted osmolality of PEG 400 solutions 
Equation 2 can be used as a tool for predicting the osmolality for PEG 400`s aqueous 200 
solutions in the range of the studied concentrations and storage conditions. 
3.2. Polyethylene glycol 4000 (PEG4000) 
Like other polyols, PEG 4000 caused an increase in the osmolality, as it acts as a 
hyperosmolar agent. 
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Graphic 3 shows the behaviour of the osmolality for the two different batches, A and B, at 205 
different concentrations and time of storage at 40 ºC. 
(Graphic 3) 
The multifactor analysis of the variance for the PEG’s 4000 osmolality indicated that all three 
factors and the interaction between them had statistically significant effect on the osmolality 
(p-value < 0.05). On the other hand, the polynomic contrast (F-value 1896 p-value < 0.01) 210 
indicated a quadratic increasing tendency of the osmolality in behalf of the concentration.  
(Graphic 4)  
The backward selection method excluded the batch variable. Graphic 4 shows the 
representation of the fitted model which explains 99.2% of the variability in the square root of 
osmolality.  215 
The equation of the fitted model is Equation 3 
 
             




                     
 
  
                     
Equation 3. Predicted osmolality of PEG 4000 solutions 
Equation 3 can be used as a tool for predicting the osmolality for PEG 4000`s aqueous 
solutions in the range of the studied concentrations and storage conditions. 220 
3.3. Poloxamer 407 
Poloxamers are synthetic block copolymers of ethylene oxide and propylene oxide, widely 
used in cosmetics and pharmaceuticals (Arbelaez-Camargo et al., 2016). They are used as 
emulsifying agents for intravenous fat emulsions, as solubilising agents to maintain clarity in 
elixirs and syrups, and as wetting agents for antibacterials (Paul J Sheskey, 2015b).  225 
Like other poloxamers, Poloxamer 407`s (P407) osmolality was expected to be insignificant 
in aqueous solutions because of its high molecular weight (12,200 g/moles), but this was not 
the case. As observed by other authors, the osmolality was described by polynomial equations 
(Viegas and Henry, 1998). 
The multifactor analysis of the variance for the P407 osmolality indicated that all three factors 230 
studied and the interaction between them had statistically significant effect on the osmolality 
(p-value < 0.05). As shown in Graphic 5, a quadratic increasing tendency of the osmolality 
was indicated by polynomic contrast (F-value 203 p-value < 0.01).. 
(Graphic 5)  
Graphic 5 shows that as the concentration of P407 increases, the osmolality increases in a 235 
non-linear way. At low concentration where the gel is not form, the curve is linear; when 
increasing the concentration, solvent-polymer interactions and intermolecular associations 
become stronger causing a loss of linearity (Viegas and Henry, 1998). The so that is bound to 
the polymer should be considered part of the solute and not part of the dissolving solvent. 
Water molecules bound to the solute more strongly than to other water molecules, making 240 
easier the elimination of water in the freezing point depression (Zavitsas, 2001). As the 
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temperature increased, the same behaviour occurred and as a result, the osmolality increased 
when stored at 40 ºC for 15 and 30 days, but in a lesser measure (Equation 4). 
 (Graphic 6)  
Graphic 6 shows the representation of the fitted model that explains the 94 % of the variability 245 
in the square root of osmolality in the studied conditions, taking into account that the 
backward selection method excluded the batch variable. 
The equation of the fitted model represented in Graphic 6.A,  
             




                  
 
  
                     
Equation 4 Predicted osmolality of P407 solutions  
Equation 4 can be used as a tool for predicting the osmolality of P407`s aqueous solutions in 250 
the range of the studied concentrations and storage conditions. 
3.4. Sodium Hyaluronate (SH) 
Hyaluronic acid is a natural polymer commonly distributed in the body. It is part of different 
body tissues and intracellular fluids as the vitreous humour and synovial fluid (Martindale, 
2016b). Sodium hyaluronate (SH) is the predominant form of hyaluronic acid at physiological 255 
pH and is the most common form used in cosmetics, parenteral, and ophthalmic 
pharmaceutical formulations (“Sodium Hyaluronate: Pharmaceutical Excipients,” n.d.). Since 
SH is widely used as an excipient in different pharmaceutical forms and as active principle for 
intra-articular treatment in knee osteoarthritis (Altman et al., 2015; Duarte et al., 2012; Hoare 
and Kohane, 2008; Ito et al., 2007; Mayol et al., 2008), knowledge of it behaviour in terms of 260 
physicochemical properties, such as the osmolality, is of great interest to predict it behaviour 
in the pharmaceutical development. With an average molecular weight of 12,220 g/moles and 
the formation of large size aggregates in solution, it was excepted to have a negligent osmotic 
effect. Graphic 7 shows the behaviour of SH aqueous solutions at different concentrations and 
times of storage at 40 ºC. As shown, the osmolality determined experimentally differed from 265 
the theoretical value. 
(Graphic 7) 
The study of the variability of the osmolality of the SH aqueous solutions due to the 
concentration and time of storage at 40 ºC was statistically analyzed. At a confidence level of 
95%, it can be stated that only the concentration has a statistically significant effect in the 270 
osmolality (p-value < 0.05) on the studied conditions. 
The SH properties are the results of the properties of a population of molecules with a wide 
chain length, as is established to be polydispersed. In solution, it behaves as a stiffened 
random coil that occupies a large hydrated volume and consequently has solute–solute 
interactions at an unusually low concentration (Hardingham, 2004).  275 
The osmolality corresponds to the concentration of osmotically active molecules, capable of 
exerting osmotic pressure. SH, a biopolymer with multiple roles in almost all biological 
tissues, has a high osmotic pressure that reinforces various physicochemical properties 
necessary to maintain the hydration and lubrication of tissues. One of the factors contributing 
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to the high observed osmolalities, is the polyelectrolytic character of the molecule due to 280 
dissociation of the counter- ion (Horkay et al., 2009). 
(Graphic 8)  
As shown in Graphic 8, a squared-SH concentration model described 96.3% of the 
relationship between the osmolality and the SH concentration. Equation 5 explained the fitted 
model. 285 
            
    
  






Equation 5. Osmolality prediction for SH solutions 
The correlation coefficient equal 0.98, indicating a relatively strong relationship between the 
variables.  
Equation 5 can be used as a tool for predicting the osmolality for HS`s aqueous solutions in 
the range of the studied concentrations and storage conditions 290 
3.5. Chondroitin Sulphate Sodium (CS) 
Chondroitin sulphate is a natural polymer present in most cartilaginous tissues. For medical 
applications, the sodium salt, chondroitin sodium sulphate, is used orally and in ocular 
surgical procedures, among others (Martindale, 2016d).  
(Graphic 9)  295 
As expected for a highly charged molecule, CS`s associated counter-ions generate an osmotic 
pressure, represented by the osmolality, that plays an important biologic effect in tissue 
hydration. The theoretical osmolality calculated from the Equation 2, considers the 
contribution of the counter-ions in the osmolality, thus, the theoretical osmolality is far from 
the observed osmolality (Graphic 9). These results reinforce the theory, that even though the 300 
electrostatic contribution is of great importance, it cannot be taken into account by itself, since 
the non-electrostatic contributions coming from the intermolecular and solute interactions also 
affect the osmolality, particularly at low concentrations in which non-electrostatic 
contributions account for about 1/3 of the total osmotic pressure (Bathe et al., 2005; Ehrlich et 
al., 1999). It is known that at low temperatures CS is stable, but in the other hand, at high 305 
temperatures and after 500-600 hours, degradation process occurs producing low-molecular-
mass fragments and desulfated products (Volpi et al., 1999), that will contribute, increasing 
the osmolality. 
The influence of the CS concentration and the time of storage at 40 ºC on the osmolality was 
evaluated at a confidence level of 95%. The results showed that the concentration, the time of 310 
storage at 40 °C and their interaction had a statistically significant effect in the osmolality (p-
value <0.05) on the studied conditions.  
A multiple linear regression using the backward selection method was applied to simplify the 
model, the result excluded the time of storage, but included the interaction between it and the 
concentration. The hierarchical principle indicates that if a model contains the interaction 315 
between two variables it must take into account both variables, whereby, the simplified model 
was not used (Bishop et al., 2007). 
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The fitted linear regression model shown in Graphic 9, explained 94.8 % of the variability in 
osmolality at a 95 % confidence level.  
(Graphic 10) 320 
Equation 6 of the fitted model is represented in Graphic 10.A 
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Equation 6 Predicted osmolality of CS solutions  
Equation 6 can be used as a tool for predicting the osmolality for CS`s aqueous solutions in 325 
the range of the studied concentrations and storage conditions 
3.6. Cremophor RH 40  
The main constituent of Cremophor RH 40 (CRE 40) is glycerol polyethylene glycol 
hydroxy- stearate, which, together with fatty acid glycerol polyglycol esters, forms the 
hydrophobic part of the product. Despite its surface active properties, CRE does not cause 330 
haemolysis and its use in pharmaceutical preparations for parenteral application (BASF SE 
Care Chemicals Division Pharma Ingredients & Services, 2008). 
Graphic 11 shows a deviation from the theoretical osmolality at concentrations higher than 
100 g/kg. This effect may be due to the molecular behaviour of the CRE 40 in solution but 
insufficient information is available to explain the deviation observed. 335 
(Graphic 11)  
The maximum CRE 40 concentration studied had an osmolality below the physiological 
osmolality, which may explain the fact that it does not cause hemolysis despite its surface 
active properties (Hork and Lais, 2002).  
The statistical study of the osmolality of Cremophor Polyoxyl 40 Hydrogenated Castor Oil 340 
evaluated at a confidence level of 95%, showed that both, the concentration and the time of 
storage at 40 °C, had statistically significant effect on the osmolality (p-value < 0.05). 
A multiple linear regression using the backward selection method was applied to simplify the 
model and excluded the storage time and the interaction between the storage time and 
concentration. 345 
(Graphic 12) 
The fitted model expressed by Equation 7 and shown in Graphic 12, explains 99.5% of the 
variability in the osmolality. at a 95 % confidence level. 
             




                    
 
  
   
Equation 7 Predicted osmolality of CRE 40 solutions  
Equation 7 can be used as a tool for predicting the osmolality for CCRE 40`s aqueous 350 
solutions in the range of the studied concentrations and storage conditions 
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3.7. Polyvinyl alcohol  
Polyvinyl alcohol (PVA) is a polar polymer widely used because of its mechanical properties, 
high melting temperature and biocompatibility (Tacx et al., 2000). It is used both alone and 
crosslinked. It is also used in the formulation of hydrogels, nanoparticles and beads.  355 
With a molecular weight of approximately 85000 g/mol, it is expected to have a negligible 
osmolality. The results obtained, as observed in the Graphic 13, showed an increase of the 
osmolality when increasing the concentration. A slight increase in osmolality due to time in 
the conditions studied was also observed. 
(Graphic 13)  360 
Statistical multifactor analysis of the osmolality indicated that both, the concentration and 
storage time at 40 ºC, had a  statistically significant effect on the osmolality (p-value < 0.05), 
but their interaction did not. This effect can be explained by the fact that PVA, in water, forms 
an intricate molecular network in which there is water of hydration bound to the polymer-free 
hydroxyl groups acting like a zipper between two polymer chains. This results in the 365 
formation of aggregates, decreasing the free water in the solution. At high temperatures there 
is a higher interaction between water and PVA molecules, breaking the zipper action; undoing 
aggregates; and facilitating the interaction of the PVA free chains with water-free molecules: 
decreasing free water molecules (Krzeminski and Molisak-tolwinska, 1991; Tacx et al., 2000; 
Vigneswari et al., 2016). 370 
A multiple linear regression using the backward selection method was applied to simplify the 
model, the result excluded the time of storage at 40 ºC and explained the 96.0 % of the 
variability in osmolality.  
(Graphic 14)  
The equation of the fitted model is: 375 
             




                
 
  
   
Equation 8. Predicted osmolality of PVA solutions  
Equation 8 can be used as a tool for predicting the osmolality for PVA`s aqueous solutions in 
the range of the studied concentrations and storage conditions 
4. Conclusions 
The data obtained from this study showed that the theoretical determination of the osmolality 380 
of the different polymers; based on molecular weight as the only determinant factor, did not 
agree with the values obtained by measurement of colligative properties, such as the freezing 
point depression. The data analysis provided an understanding of the osmolality behaviour of 
the different studied polymers in aqueous solution and its evolution over a period at the 
hypothetical worst case of storage temperature. Application of this knowledge would facilitate 385 
primary galenic development of safe parenteral and ophthalmic dosage forms in terms of 
osmolality, by its estimation using the predictive obtained equations. 
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We agree that there is a lack of information on the determination of osmolality by freezing point 
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3) There is a statement in the theory section about osmotic pressure on of polymers being more of a 
function of molecular weight and interactions than on number of particles. However, osmotic 
pressure per se is not reported in this paper. It seems to be assumed however that the reader will 
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40`s after their preparation (time zero) and after 15 and 30 days of storage. Theoretical 
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Graphic 13. Experimental osmolalities of differently concentrated aqueous solutions of 
PVA’s after their preparation (time zero) and after 15 and 30 days of storage. Theoretical 
osmolalities of differently concentrated aqueous solutions of PVA, estimated using Equation 
1.2.  
Graphic 14. (A) PVA’s osmolality square root for linearization to describe the original 
nonlinear model and the fitted model. (B) Observed vs Predicted Scatter Plot. 
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